Insiders PTC Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 08/05/2024 BST			5-day change	1st Jan Change
31.14 ^USD	-2.04%		-8.84%	+12.99%

04-30	North American Morning Briefing : More Earnings -2-	DJ
04-29	Morgan Stanley Upgrades PTC Therapeutics to Equalweight From Underweight, Adjusts PT to $30 From $28	MT

Ptc Therapeutics Insider Sold Shares Worth $273,804, According to a Recent SEC Filing	01-24	MT
Replimune Group Appoints Emily Hill as CFO	19/09/23	MT
Insider Sell: Ptc Therapeutics	08/09/23	MT
Fennec Pharmaceuticals Reports Q2 2023 Net Loss of US$5.4 Million; Appoints Adrian Haigh as Chief Operating Officer	03/08/23	MT
PTC Therapeutics Names New CFO	17/07/23	MT
PTC Therapeutics, Inc. Appoints Pierre Gravier as Chief Financial Officer	17/07/23	CI
Insider Sell: Ptc Therapeutics	23/05/23	MT
Insider Sell: Ptc Therapeutics	12/05/23	MT
Insider Sell: Ptc Therapeutics	25/04/23	MT
Insider Sell: Ptc Therapeutics	19/04/23	MT
Insider Sell: Ptc Therapeutics	19/04/23	MT
Insider Sell: Ptc Therapeutics	29/03/23	MT
Insider Sell: Ptc Therapeutics	29/03/23	MT
Insider Sell: Ptc Therapeutics	29/03/23	MT
PTC Therapeutics Shares Fall After Chief Executive Officer Exit Announcement	24/03/23	MT
PTC Therapeutics Chief Executive Stuart Peltz Retiring, Chief Operating Officer Matthew Klein Named Successor	24/03/23	MT
PTC Therapeutics, Inc. Announces CEO Changes	24/03/23	CI
PTC Therapeutics, Inc. Appoints Matthew Klein to Board of Directors	24/03/23	CI
Insider Sell: Ptc Therapeutics	02/02/23	MT
Insider Sell: Ptc Therapeutics	12/01/23	MT

No results for this search